Iranian Guidance and Recommendation for the Diagnosis and Treatment of Osteoporosis and Sarcopenia: Position Statement Executive Summary

Osteoporosis is the most common metabolic bone disease. It is a chronic disease and a socio-economic threat. The aim of this study was to develop a clinical guideline for osteoporosis to integrate service delivery. This study was designed and conducted in two phases: comprehensive systematic review and expert panel method. First, a comprehensive search of sources was conducted in reliable databases. Then, in the expert panel phase, the clinical questions and recommendations were presented to members of the panel of experts. Finally, among various recommendations for a clinical question, the recommendation, which was approved by more than 70% of the panel of experts, was chosen as the final recommendation. By reviewing the valid guidelines of the world, five guidelines were selected according to the screening criteria of the study and entered into the study. After holding several sessions with the panel of experts and reviewing the recommendations in the initial version, 28 questions and 181 recommendations were extracted. After obtaining the opinions of professors from different disciplines, the final recommendations were reviewed in a meeting with clinical experts, and based on the submitted opinions, the final version of the guideline update, in the form of 34 questions and 111 recommendations in the field of bone health (four questions, 12 recommendations), diagnosis and Evaluation (six questions, 19 recommendations), treatment and rehabilitation (17 questions, 67 recommendations), and Sarcopenia (seven questions, 13 recommendations), were presented. Due to the emphasis on the need for accessing valid protocols to provide optimal and useful services and address the care gap has developed the Osteoporosis Clinical Guide.